BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8701872)

  • 1. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
    Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K
    Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
    Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
    J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART]).
    Daida H; Kuwabara Y; Yokoi H; Nishikawa H; Takatsu F; Nakata Y; Kutsumi Y; Oshima S; Nishiyama S; Ishiwata S; Kato K; Nishimura S; Miyauchi K; Kanoh T; Yamaguchi H
    Am J Cardiol; 2000 Sep; 86(5):550-2, A9. PubMed ID: 11009277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Lee YJ; Daida H; Yokoi H; Miyano H; Takaya J; Sakurai H; Mokuno H; Yamaguchi H
    Jpn Heart J; 1996 May; 37(3):327-32. PubMed ID: 8774625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?
    Kanemitsu S; Takekoshi N; Matsui S; Tsugawa H; Ohkubo S; Kitayama M; Matsuda T; Senma J; Masuyama K; Yamagata T; Murakami E
    Ther Apher; 1998 Feb; 2(1):65-70. PubMed ID: 10227791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty.
    Setsuda M; Inden M; Hiraoka N; Okamoto S; Tanaka H; Okinaka T; Nishimura Y; Okano H; Kouji T; Konishi T
    Clin Ther; 1993; 15(2):374-82. PubMed ID: 8519045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preventive effect of pravastatin on restenosis following coronary angioplasty: prospective randomized trial].
    Iwasaki K; Kusachi S; Hina K; Yamasaki S; Nishiyama O; Takaishi A; Kita T; Taniguchi G
    J Cardiol; 1995 Jan; 25(1):15-21. PubMed ID: 7877098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty. Ichilov Magnesium Study Group.
    Roth A; Eshchar Y; Keren G; Sheps D; Kerbal S; Laniado S; Miller HI; Rubinstein A
    Am J Cardiol; 1994 Jun; 73(16):1154-8. PubMed ID: 8203331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    O'Keefe JH; Stone GW; McCallister BD; Maddex C; Ligon R; Kacich RL; Kahn J; Cavero PG; Hartzler GO; McCallister BD
    Am J Cardiol; 1996 Mar; 77(8):649-52. PubMed ID: 8610621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduction in the rates of restenosis after coronary angioplasty with simvastatin and probucol].
    Merchán Herrera A; López Mínguez JR; Alonso Ruiz F; Escola JM; Címbora Ortega A; Poblador Curto MA; Redondo Méndez A; Romero Santisteban R; Geniz Gallardo I; González Fernández R; Millán Núñez V
    Rev Esp Cardiol; 1999 Oct; 52(10):778-84. PubMed ID: 10563153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.
    Tardif JC; Côté G; Lespérance J; Gosselin G; Joyal M; de Guise P; Bilodeau L; Doucet S; Harel F; Couturier A; Gallo R; Grégoire J
    Can J Cardiol; 2001 Jan; 17(1):49-55. PubMed ID: 11173314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
    Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
    Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of serum lipid level for restenosis following initial successful percutaneous transluminal coronary angioplasty in patients with unstable angina].
    Kishi K; Hiasa Y; Tanaka H; Tanimoto M; Kinoshita M; Shinohara A; Wada T; Aihara T
    J Cardiol; 1996 Aug; 28(2):79-84. PubMed ID: 8814525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can aggressive lipid lowering using low-density lipoprotein apheresis prevent restenosis after percutaneous transluminal coronary angioplasty in patients with normocholesterolemia?
    Yamashita K; Tasaki H; Tsuda Y; Himeno E; Nakashima Y
    Ther Apher; 1998 Aug; 2(3):210-7. PubMed ID: 10227772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of restenosis after angioplasty in small coronary arteries with probucol.
    Rodés J; Côté G; Lespérance J; Bourassa MG; Doucet S; Bilodeau L; Bertrand OF; Harel F; Gallo R; Tardif JC
    Circulation; 1998 Feb; 97(5):429-36. PubMed ID: 9490236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pravastatin on prevention of restenosis after successful percutaneous transluminal coronary angioplasty.
    Onaka H; Hirota Y; Kita Y; Tsuji R; Ishii K; Ishimura T; Kawamura K
    Jpn Circ J; 1994 Feb; 58(2):100-6. PubMed ID: 8196151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty.
    Tenda K; Saikawa T; Maeda T; Sato Y; Niwa H; Inoue T; Yonemochi H; Maruyama T; Shimoyama N; Aragaki S
    Jpn Circ J; 1993 Aug; 57(8):789-95. PubMed ID: 8355396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.
    Cooke T; Sheahan R; Foley D; Reilly M; D'Arcy G; Jauch W; Gibney M; Gearty G; Crean P; Walsh M
    Circulation; 1994 Apr; 89(4):1593-8. PubMed ID: 8149526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of restenosis by lovastatin after successful coronary angioplasty.
    Sahni R; Maniet AR; Voci G; Banka VS
    Am Heart J; 1991 Jun; 121(6 Pt 1):1600-8. PubMed ID: 2035374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.